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ABSTRACT 
Breast cancer cell invasion is a highly orchestrated process driven by a myriad of complex 
microenvironmental stimuli. These complexities make it difficult to isolate and assess the 
effects of specific parameters including matrix stiffness and tumor architecture on disease 
progression. In this regard, morphologically accurate tumor models are becoming 
instrumental to perform fundamental studies on cancer cell invasion within well-controlled 
conditions. In this study, the use of photocrosslinkable hydrogels and a novel, two-step 
photolithography technique was explored to microengineer a 3D breast tumor model. The 
microfabrication process presented herein enabled precise localization of the cells and 
creation of high stiffness constructs adjacent to a low stiffness matrix. To validate the 
model, breast cancer cell lines (MDA-MB-231, MCF7) and normal mammary epithelial 
cells (MCF10A) were embedded separately within the tumor model and cellular 
proliferation, migration and cytoskeletal organization were assessed. Proliferation of 
metastatic MDA-MB-231 cells was significantly higher than tumorigenic MCF7 and 
normal mammary MCF10A cells. MDA-MB-231 exhibited highly migratory behavior and 
invaded the surrounding matrix, whereas MCF7 or MCF10A cells formed clusters that 
were confined within the micropatterned circular features. F-actin staining revealed unique 
3D protrusions in MDA-MB-231 cells as they migrated throughout the surrounding matrix. 
Alternatively, there were abundance of 3D clusters formed by MCF7 and MCF10A cells. 
The results revealed that gelatin methacrylate (GelMA) hydrogel, integrated with the two-
step photolithography technique, has great promise in creating 3D tumor models with well-
defined features and tunable stiffness for detailed studies on cancer cell invasion and drug 
responsiveness. 
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CHAPTER 1  
INTRODUCTION 
1.1 BURDEN OF BREAST CANCER 
Breast cancer is the second highest cause of cancer related deaths in the United 
States. According to the National Cancer Institute, over 200,000 cases of invasive breast 
cancer are expected to be diagnosed in the U.S., in 2015, and nearly 20% of these 
individuals are estimated to succumb to it. Women in the age range of 55-64 years are seen 
to be more prone to die of breast cancer with the risk increasing with age. Studies have 
shown that in women with a family history of breast cancer, the risk increases two to three-
fold. Other minor risk factors/early indicators for breast cancer include early onset of 
menstruation, late menopause, first full-time pregnancy at a late age, breastfeeding for less 
than a year, use of oral contraceptives and BRCA1, BRCA2 gene mutations (Kelsey and 
Bernstein 1996). However, most cases of breast cancer occur and are detected in women 
who have no perceptible risk factors (Kelsey and Bernstein 1996).  
Breast cancer cases have been recorded for thousands of years and have primarily 
been treated using surgical procedures (Rayter 2003). Early cases, reported by the 
Egyptians, were treated by cauterizing the tissue that was afflicted by the disease, with a 
tool called a “fire drill”. Dr. Henry LeDran, in 1757, was one of the pioneers to propose 
the theory that breast cancer begins as a local disease but spreads to neighboring as well as 
distant organs through the circulatory system (Rayter 2003). In the mid-1800s, surgeons 
started to keep a more detailed account of breast cancer. They noted that even after a 
mastectomy, there was a high recurrence rate of the disease due to its spread to nearby 
glands or lymph nodes (Rayter 2003). When breast cancer was observed to recur near the 
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surgical site, Charles Moore, cancer specialist at the Middlesex Hospital in London, 
established some principles that involved removal of surrounding tissues and infected 
axillary glands (Rayter 2003).  
Metastasis of the tumor to secondary sites results in a poor prognosis of the patient, 
and there has not been a definitive way to detect and combat it. Thus, in recent years, there 
have been numerous attempts at studying breast cancer metastasis and invasion. In 
particular, there has been increasing focus on how the tumor microenvironment contributes 
to changes in cancer cell behavior and, motility (Wang, Eddy, and Condeelis 2007). 
Modern studies using technologies based on imaging and profiling focus on identification 
of molecular pathways that can lead to diagnostic and therapeutic approaches to treat breast 
cancer. 
1.2 METASTASIS  
Metastasis, the primary cause of mortality among individuals with breast cancer, is 
the spread of cells from the primary tumor site to distant organs (Nguyen, Bos, and 
Massagué 2009). There are several steps in the metastatic cascade (Figure 1.1) and 
including  the epithelial-mesenchymal transition (EMT), degradation of the basement 
membrane, invasion of surrounding tissue, intravasation of tumor cells into the neighboring 
blood vessels, transportation of tumor cells through the vasculature, arresting of the tumor 
cells and their extravasation, and formation of the secondary tumor along with extracellular 
matrix (ECM) remodeling and angiogenesis (Geiger and Peeper 2009). The successful 
completion of each of these stages would result in metastasis and the development of a 
secondary tumor (Figure 1.1 (7)). A cancer cell might fail to complete any one of the stages 
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of the metastatic cascade and it would result in unsuccessful metastasis. Thus, metastasis 
is considered to be an inefficient process (Wong et al. 2001). 
Figure 1.1: The metastatic cascade (1) Normal organ lined with epithelial cells bound by 
the basement membrane (2) epithelial-mesenchymal transition, (3) degradation the 
basement membrane and invasion into the surrounding tissue, (4) intravasation into 
neighboring blood vessel (5) transport through the vasculature, arrest of tumor cells, (6) 
extravasattion from the blood vessel and (7) formation of tumor in the secondary site.  
The ‘seed and soil’ hypothesis that Paget proposed in 1889 based on the data 
collected from 735 women suffering from breast cancer states that cancer cells, “the seed”, 
need a conducive environment, “the soil”, to metastasize, thrive and form a tumor in a 
distant organ (secondary tumor) (Paget 1989). The conducive environment is called the 
premetastatic niche and promotes the invasion of the tumor cells into surrounding tissue. 
Initiation and development of the pre-metastatic niche is observed to originate from many 
different factors. Apart from factors such as the presence of stromal-derived factor 1 (SDF-
1) chemokine, the pre-metastatic niche contains microenvironmental components such as 
fibroblasts and endothelial cells which secrete growth factors and chemokines that 
influence tumor cell polarity, circulation, and migration (Kucia et al. 2005, Orimo et al. 
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2005). Therefore, before tumor cells initiate the first step of metastasis, a receptive 
microenvironment assembles, which eventually promotes the formation of the secondary 
tumor.  
Most solid tumors arise from epithelial cells, and metastasis is initiated with the 
cells undergoing the EMT. The EMT starts as cells lose their epithelial polarity and 
epithelial proteins such as E-cadherin, cytokeratins and catenin proteins get downregulated 
(Christofori 2006, Jechlinger et al. 2003). Furthermore, the EMT promotes metastasis by 
allowing cancer cell invasion with the loss of cell-cell adhesion (Perl et al. 1998), secreting 
matrix metalloproteinases (MMPs) which aid in degrading the proteins of the ECM 
(Giannelli et al. 1997), overexpressing mesenchymal proteins like N-cadherin (Hazan et al. 
2000, Nieman et al. 1999), and inhibition of apoptosis (Maestro et al. 1999, Vega et al. 
2004). Invasion is the second step in metastasis which will be discussed in detail in the 
next section, owing to its relevance to this study. Angiogenesis, a hallmark of cancer, is 
the process by which new blood vessels grow from pre-existing vessels. For a tumor to 
grow and metastasize to distant organs, it needs to be part of a vascularized network and 
gain access to necessary nutrients and oxygen. Tumors which do not have vascularized 
networks have historically not grown past 1 mm in size (Gimbrone et al. 1972, Bergers and 
Benjamin 2003, Kalluri 2003). In adults,  angiogenesis is typically rare and strictly kept in 
check, but during tumor progression, vascularization is activated with the help of factors 
such as epidermal growth factor (EGF), vascular endothelial growth factor A (VEGF A), 
and fibroblast growth factor (FGF) (Bergers and Benjamin 2003, Kalluri 2003). The 
angiogenic switch is an important step for the tumor to grow to a disproportionate size 
(Bergers and Benjamin 2003).  
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In the next step of metastasis, cancer cells spread to distant organs by entering and 
getting transported through the blood vessels. In a study where metastatic breast cancer 
cells were injected into a mouse, it was observed that the tumor cells direct and orient 
themselves along the blood vessels (Li et al. 2000). Tumor cells can also enter lymph 
vessels passively as has been seen in a pancreatic β-cell tumor mouse model (Geiger and 
Peeper 2009). Large tumors spew/shed millions of tumor cells into circulation every day, 
but since metastasis is a very inefficient process, very few of them survive (Cameron et al. 
2000). Once the cells enter the circulatory system, a large number of them might be 
eliminated due to anoikis; the process of programmed cell death or apoptosis caused due 
to loss or inadequate cell adhesion (Paoli, Giannoni, and Chiarugi 2013), due to the force 
of blood flow. In the first few hours after tumor cells attach to the wall of the blood vessel, 
extravasation occurs with the help of cytoplasmic protrusions and deformations (Tsuji et 
al. 2006). The cancer cells may proliferate within the blood vessels and extravasation may 
occur when these cells outgrow the vascular structures, destroying the vessel boundary in 
the process (Wong et al. 2002). Most of the cells after extravasation undergo apoptosis in 
the first 24 hours. Lack of adhesion cues and several other external factors may lead to 
anoikis of tumor cells at the secondary site. One of the factors of anoikis is the release of 
cytotoxic products by the surrounding cells and another factor is the presence and action 
of immune cells on the cancer cells. The tumor cells are seen to survive as individual, a 
small group or a large group of cells and remain dormant for a long period of time.  
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1.3 INVASION  
Invasion is a subcategory of metastasis when the cancer cells must attain the ability 
to migrate in order to invade tissues and blood vessels. Membrane protrusions such as 
lamellipodia, filopodia, pseudopods and invadopods (Adams 2001) assist in the migration 
and invasion of the tumor cells through actin polymerization and depolymerization. 
Mesenchymal mode of cell migration is accomplished with a few inter-reliant steps. The 
first step in migration is cell polarization and elongation. Further, a pseudopod is formed 
at the leading edge, which attaches to the ECM substrate. Finally, the cell body contracts, 
pulling the trailing edge and the cell body forward by generating traction forces (Friedl and 
Wolf 2003). The role of integrins and focal complexes growing and stabilizing into focal 
contacts emerges after the cell elongates and comes in contact with the ECM (Friedl and 
Wolf 2003). Both integrin and non-integrin receptors play a prominent role in the formation 
of focal contacts and consequently, migration and invasion through the basement 
membrane (BM) with the help of recruited proteases (Friedl and Wolf 2003). 
In the context of breast cancer, carcinoma in situ (CIS) begins with the neoplasm 
contained within the BM and in ductal carcinoma in situ (DCIS), the BM is altered even 
though it is intact (Kalluri and Zeisberg 2006). The transition from DCIS to invasive ductal 
carcinoma (IDC) includes degradation of the BM and subsequently, the “reactive stroma” 
as the cancer cells coming in contact with each other. The subsequent changes in gene 
expressions is followed by transitions like the EMT and, eventually, migration and invasion 
of the cancer cells (Kalluri and Zeisberg 2006). 
Breast cancer cells can disseminate from the primary tumor and adopt a 
heterogenous morphology while invading (van Zijl, Krupitza, and Mikulits 2011). If the 
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cancerous cells lose one particular migration ability, they develop an alternate migratory 
approach owing to the fact that cancer cells express varying degrees of proteases and 
integrins (van Zijl, Krupitza, and Mikulits 2011). This phenomenon of developing an 
alternate method of migration is called ‘plasticity’. Consequently, the cancer cells can 
invade as individual cells, lines, sheets or clusters, which demonstrates changes such as 
EMT and mesenchymal to amoeboid transition (MAT) (van Zijl, Krupitza, and Mikulits 
2011). Such behavior can either occur due to changes in the microenvironment like 
modifications in the substrate adhesiveness, cell-cell adhesions, need for ECM proteolysis 
or due to drug treatments such as protease, MMP inhibitors, etc. (Geiger and Peeper 2009). 
The characteristics of amoeboid cell invasion are loss of polarity, limited 
attachment, and no remodeling of the ECM (Condeelis and Segall 2003). Amoeboid 
migration is faster because cells need less adhesion contacts and no ECM remodeling. 
Amoeboid cell invasion does not depend on proteases; it makes use of mechanical forces 
to displace matrix fibrils instead of completely degrading them (Sabeh, Shimizu-Hirota, 
and Weiss 2009). MAT frequently comes into picture when cancer is being treated with 
inhibitors (Wolf et al. 2003). Another form of cell invasion is collective cell invasion and 
its three main characteristics are maintenance of intact cell-cell junctions (Friedl et al. 
2004), generation of traction force by coordination of polarity (Hegerfeldt et al. 2002) and, 
cytoskeletal reorganization, remodeling of the ECM and basement membrane (Wolf et al. 
2007). Collective cell invasion can assume many forms such as a monolayer that invades 
two-dimensionally or cell strands and clusters that can invade tissues in three dimension 
(3D). The reduction in polarity of luminal epithelial cells in breast cancer tumors causes 
collective cell migration, and consequently, the cancer switches from in situ to invasive 
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carcinoma (Gray, Cheung, and Ewald 2010). The main requirements in collective cell 
migration is that the cells have to preserve their cell-cell contacts (Friedl and Gilmour 2009, 
Friedl et al. 2004), and the collective movement has to generate a traction force, which is 
majorly given by the integrins present in the leading cells (Gaggioli et al. 2007). The tumor 
cells, contrary to normal cells, are promoted by non-existent stop signals to the migratory 
events (Friedl and Wolf 2003). This lack of balance drives the tumor cells to invade the 
surrounding tissues and migrate to the distant organs.  
1.4 COMPLEXITIES OF THE BREAST TUMOR MICROENVIRONMENT 
The two leading theories on the instigation of breast cancer are “cancer stem cell 
hypothesis” and “stochastic model of carcinogenesis”. A major concept behind cancer stem 
cell hypothesis is that tumors are derived from tissue stem cells or progenitor cells through 
a dysregulation of the self-renewal pathway (Wicha, Liu, and Dontu 2006). Owing to this 
property, the tumors will preserve stem cell characteristics which lead to self-renewal, 
differentiation and heterogeneity in the cancer cells (Wicha, Liu, and Dontu 2006). On the 
other hand, in the stochastic model of carcinogenesis, it is hypothesized that tumorigenesis 
occurs due to random mutations in the breast epithelial cells like stem, differentiated or 
progenitor cells (Sgroi 2010). It has been postulated that the accumulation of genomic 
instability in the stroma might lead to genomically unstable epithelium and consequently, 
neoplastic transformation (Weber et al. 2006). In addition, a number of observations in 
human patients have led to the postulation that mutations and, consequently, tumorigenesis 
can be promoted by the host microenvironment (Artacho-Cordón et al. 2012).  
The components of the microenvironment (Figure 1.2) play a crucial role in 
regulating carcinogenesis (Place, Jin Huh, and Polyak 2011). The native breast 
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microenvironment is composed of both stromal components and ECM. The surrounding 
stroma includes fibroblasts, adipocytes, endothelial cells as well as immune cells (Place, 
Jin Huh, and Polyak 2011). The ECM that principally interacts with the epithelium is the 
BM which is primarily composed of collagen type IV, laminin (LM) (LM-111 and LM-
332), glycoproteins (epiligrin and entactin) and proteoglycans (Oskarsson 2013). The ECM 
helps to maintain tissue structure and architecture as well as homeostasis of mature tissues. 
Initially, the tumor starts off as CIS, which is a neoplasm arising from the epithelial cells 
and contained within a boundary known as the basement membrane (Kalluri and Zeisberg 
2006). The surrounding stroma plays a crucial part in cancer progression and researchers 
have tried to elucidate this role by performing various studies. In each step of metastasis, 
it can be seen that stromal components play an important role. For example, endothelial 
cells are recruited in large numbers to the tumor site and promote angiogenesis, and 
macrophages secrete cytokines that enhance tumor cell invasion (Khamis, Sahab, and Sang 
2012). For instance, in a study where breast cancer cells were co-cultured with adipocytes, 
they were seen to exhibit increased invasion characteristics (Dirat et al. 2011).  
Cancer associated fibroblasts (CAFs) are the most abundant component in the 
tumor stroma. CAFs can originate from different sources which include resident fibroblasts 
which get activated, mesenchymal stem cells, cells that undergo EMT and 
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Figure 1.2: Major components of the breast tumor microenvironment 
endothelial-mesenchymal transition (Mao et al. 2013). It is reported that CAFs promote 
proliferation and growth of precancerous breast epithelial cells (Mao et al. 2013), induce 
EMT (Hugo et al. 2012) and promote angiogenesis which are steps towards metastasis of 
the cancer. Furthermore cancer cells secrete chemokine factors which recruit macrophages 
and aid their intravasation into blood vessels (Tsuyada et al. 2012). There also have been 
reports of carcinoma cells reversing their malignant phenotype and integrating themselves 
into normal tissue when placed with normal breast epithelial cells (Bussard et al. 2010). 
Cancer cells respond and redirect their development and maturation. This is evidenced by 
experiments where human embryonal carcinoma cells were incorporated into the 
mammary gland epithelium of a mouse, played an instrumental role in the formation of 
mouse mammary gland structures (Bussard et al. 2010). Another example is where 
transplanted mammary cancer cells gave rise to normal ductal structures six months after 
transplantation into cleared mouse fat pads (Maffini et al. 2005). The reported results 
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demonstrated that CAFs and the other stromal components play a prominent role in breast 
cancer growth, progression and metastasis or reversion of cancer cells to normal behavior.  
A plethora of mechanical forces, due to the properties of the ECM, acting on the 
cancer cells from outside can also alter their phenotype and consequently their migratory 
behavior (Artacho-Cordón et al. 2012). Collagen type I is the most dominant component 
in the breast ECM and plays a very important role in the developmental stages (i.e. the 
formation of mammary ducts) (Keely, Wu, and Santoro 1995). Matrix stiffness plays a 
major role in cell morphogenesis and it is seen that there is an increase in deposition of the 
different types of collagen (types I and III) during the formation of the tumor (Kauppila et 
al. 1998). A number of studies have shown that breasts with high collagen density have an 
increased risk of developing breast cancer (Boyd et al. 2001). Furthermore, an increase in 
matrix stiffness can influence integrin adhesions, increase Rho activity and lead to 
abnormal tissue growth and morphology (Paszek et al. 2005). For instance, it has been 
observed that in substrates with native tissue stiffness, mammary epithelial cells form 
acinus-like structures, whereas in matrices with higher stiffness, the cells lost polarity and 
cell-cell junction proteins (Butcher, Alliston, and Weaver 2009). This is indicative of the 
epithelial cell transformation, which is a step towards tumorigenesis. These findings 
indicate that breast microenvironment including the matrix stiffness, tissue architecture and 
biochemical cues plays an important role in the tumor development and disease 
progression.  
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1.5 LIMITATIONS OF CONVENTIONAL ASSAYS AND IN VIVO MODELS FOR 
CANCER INVASION STUDIES 
In vivo models have been widely used in the study of breast cancer initiation, 
growth and progression. Based on the facet of the disease to be studied, the choice of animal 
model is critical. Chemically-induced rodent models (Russo and Russo 1996), human 
xenograft models (Clarke 1996) and transgenic mouse models (Hutchinson and Muller 
2000) are some of the animal models that are extensively used. Genetically engineered 
mouse models (GEM) gained popularity over other models because of their ability to 
manipulate genes and provide seemingly accurate models for studying cancer and effects 
of cancer therapeutics (Van Dyke and Jacks 2002). The use of animal models are an 
essential stage in the preclinical phase but it is observed that they can accurately depict 
only the initial stages of tumor growth and progression (Van Dyke and Jacks 2002). 
Chemoprevention of cancer studies in GEM models are observed to have an attractive 
potential (Green et al. 2001, Alexander 2000). Mouse models have also been observed to 
have a good scope in studying and treatment of leukemia and lymphomas as opposed to 
solid tumors as well as in testing some of the therapies that target specific genes or 
pathways (Bibby 2004). Also, most of the xenograft models used in the pharmaceutical 
industry are human tumors placed subcutaneously into the animals and they lack the 
necessary host-tumor interactions. To overcome the limitations of subcutaneous 
transplantations, there have been advances towards orthotopic transplantations where the 
xenograft is placed in the physiologically relevant area of the mouse model (Bibby 2004). 
For example, in case of breast cancer, the xenograft would be placed in the mammary fat 
pads of the mouse model to mimic breast tumor development in humans. Other challenges 
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encountered while using in vivo models are the lack of control over the tumor 
microenvironment and difficulty in real-time imaging as well as imaging of fixed samples 
(Yamada and Cukierman 2007).  
The majority of conventional studies on cancer migration have been conducted 
using two dimensional (2D) models because of the ease and convenience to set 
experiments. However, these models do not accurately depict the in vivo tissue structures 
required for the necessary cell-cell and cell-matrix interactions. In this regard, significant 
knowledge has been gained on cellular motility and migration from studies conducted on 
2D surfaces. There have been exhaustive studies on the physical and molecular machinery 
that help movement and migration of cells (Ridley et al. 2003, Pollard and Borisy 2003, 
Lauffenburger and Horwitz 1996). When comparing normal cells with tumorous ones, 2D 
monolayer cultures might be useful in determining certain characteristics such as the 
replicating potential and functionalities of the cell (Khoruzhenko 2011). In breast cancer, 
creating a tumor model with physiologically accurate stromal components is crucial 
because more than 80 percent of the mammary gland is composed of the stroma (Kim 
2005). Furthermore, culturing tumor cells in 2D monolayers will not promote the necessary 
cell-ECM interactions due to the lack of tissue structure (Kim 2005). It is seen that when 
normal epithelial cells are cultured on 2D substrates, they exhibit cancer cell traits 
(Petersen et al. 1992). The most important trait of mammary epithelial cells is their polarity 
which in vivo, helping the formation of acini structure and results in mammary 
morphogenesis. When cultured on 2D substrates, epithelial cells lose their polarity and 
cannot be seen forming any relevant physiological structures. Also, in case of focal 
adhesion exhibited by cells, large focal adhesions are observed in 2D culture whereas the 
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same cells demonstrate focal adhesions of decreased size when cultured in 3D matrices 
(Fraley et al. 2010). These comprehensive studies show that when culturing cells on 2D 
substrates, important characteristics such as chemical signaling, protein composition, and 
cell-cell/cell-matrix interactions are often lost or substantially inhibited (Fraley et al. 2010, 
Kim 2005, Petersen et al. 1992).   
In vitro analysis of cancer therapeutics is a crucial step before the drugs are tested 
on relevant animal models. Although, 2D monolayers are the conventional assays that are 
currently in use for drug testing, it is evident that there is a need for a more relevant alternate 
model (Kunz-Schughart et al. 2004). It is crucial to eliminate the poor drug candidates in 
the earlier stages with the help of better designed in vitro assays (Kunz-Schughart et al. 
2004). The need is the development of relevant in vitro assays that make use of human-
derived cells or tissues for preclinical pharmacological testing (Mazzoleni, Di Lorenzo, 
and Steimberg 2009). In case of modeling breast tissue, it is necessary to have matrices 
that represent ECM to which the epithelial cells can attach, exhibit normal functions like 
proliferation, differentiation and form physiologically relevant structures like acini 
(Bissell, Rizki, and Mian 2003).  
1.6 HYDROGEL AND POLYMERIC BIOMATERIALS TO CREATE 3D 
MICROENVIRONMENT FOR CANCER STUDIES 
Hydrogels used in tissue engineering are polymers that have high water content, 
and properties that can be manipulated to mimic the ECM to provide the essential 
biophysical cues to the cultured cells (Seliktar 2012). For the cells to grow and respond to 
the microenvironment, it is important that the substrate exhibit molecular composition and 
mechanical stiffness similar to the native ECM. Therefore, initially, the development of 3D 
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tumor microenvironment was performed utilizing biomaterials derived from natural origins 
such as collagen, Matrigel and hyaluronic acid (HA) (Alemany-Ribes and Semino 2014). 
In this regard, the presence of ECM binding motifs in the biomaterial used for creating the 
microenvironment is crucial (Alemany-Ribes and Semino 2014). The Bissel lab performed 
pioneering work in creating 3D models to recapitulate normal as well as cancerous breast 
tissue microenvironment (Bissell, Rizki, and Mian 2003). Various studies have been 
conducted to study invasion and migration of tumor cells using naturally derived 
biomaterials (Poincloux et al. 2011, Nguyen-Ngoc et al. 2012, David et al. 2004). Apart 
from biomaterials such as collagen I, Matrigel and HA, another biomaterial used for 
modeling breast tumor in vitro is a silk fibroin protein called Antheraea mylitta fibroin 
protein which is isolated from tasar silkworm (Talukdar et al. 2011, Mira et al. 2004).  
Synthetic biomaterials were developed in order to overcome certain limitations of 
naturally derived biomaterials such as lack of ability to pattern the matrix and manipulate 
stiffness (Lutolf 2009, Langer and Tirrell 2004). Polyethylene glycol (PEG) (Loessner et 
al. 2010), poly(lactide-co-glycolide) (PLG) (Fischbach et al. 2007), Poly(lactic acid) (PLA) 
and combinations like Poly(lactic-co-glycolic acid) (PLGA) (Sahoo, Panda, and 
Labhasetwar 2005) are some of the widely used synthetic biomaterials. Synthetic polymers 
have inferior cell adhesion properties as compared to their natural counterparts, however, 
they can be functionalized with certain ECM components in order to improve the ability of 
the cells to adhere (Nyga, Cheema, and Loizidou 2011). For instance, in one study, PEG 
functionalized with RGD peptide which is an ECM binding motif was used to culture 
epithelial ovarian cancer cells (Loessner et al. 2010). This study was focused on comparing 
the drug resistance of cells cultured on 2D versus 3D and it was observed that more cells 
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were viable in 3D matrix as compared to 2D substrates after the drug treatment (Loessner 
et al. 2010). This study validated the hypothesis that testing drugs on 2D cell monolayers 
might not give conclusive results for use of drugs in patients. There have been similar 
research work for studying cell behavior and drug testing using synthetic biomaterials 
including PLG scaffolds (Fischbach et al. 2007), PLGA, PLA with poly(vinyl alcohol) 
(PVA) (Sahoo, Panda, and Labhasetwar 2005). To create better in vivo models than 
xenografts, hydrogels can be used to inject breast cancer cells into the mammary fat pads 
of the mouse (Liu, Shu, and Prestwich 2007). Thus, the 3D engineered approach might 
provide a better representation of tumor progression than the traditional xenograft models.  
1.7 MICROFABRICATED PLATFORMS TO STUDY CANCER CELL 
BEHAVIOR 
BioMEMS (Bio Microelectromechanical Systems) is an extension of MEMS 
technologies used for biomedical applications. These technologies help in fabricating 
microscale systems with feature sizes ranging from less than 1 µm to greater than 1 cm 
(Whitesides et al. 2001). A subset of microfabrication techniques are found to be 
compatible with cells and in conjunction with biomaterials can be used for creating 
miniaturized platforms for fundamental biological studies and drug screening 
(Khademhosseini et al. 2006). Soft lithography is a set of microfabrication techniques such 
as microcontact printing and microfluidic patterning. Soft lithography can be used to 
precisely control the distribution of proteins in specific geometries on the substrate to 
which cells could be added or micropattern biomaterials which have cells seeded in or 
encapsulated in them (Zorlutuna et al. 2012, Khademhosseini et al. 2006).  
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Microfabricated 2D in vitro models have been used to study cell-cell, cell-substrate 
interaction as well as for drug screening (Whitesides et al. 2001). Microcontact printing, 
stencil and microfluidic patterning have been used to pattern cells on ECM mimicking 
substrates (Whitesides et al. 2001). In microcontact printing, a polydimethylsiloxane 
(PDMS) stamp manufactured with a chosen pattern and coated with the desired proteins is 
brought in contact and transferred onto the substrate based on the differences between the 
hydrophobicity of the surfaces (Whitesides et al. 2001). The cells that are delivered on to 
the surface as a solution or suspension preferentially adhere to the patterned proteins and 
form a 2D micropatterned platform (Whitesides et al. 2001). For instance, in a recent study, 
Dickinson et al. used microcontact printing (Figure 1.3 (A)) for patterning HA and 
fibronectin (Fn) surfaces to study the adherence and interactions between endothelial and 
breast cancer cells (Dickinson et al. 2012). Some of the disadvantages of microcontact 
printing are protein denaturation during patterning, need for multiple stamps to create 
complex designs and deformation of the stamp after a number of uses (Huang 2013). The 
above mentioned techniques are useful only for patterning acellular substrates where the 
cells would preferentially adhere to the patterned surfaces (Whitesides et al. 2001, Folch 
et al. 2000). However, the major disadvantage associated with microcontact printing, 
stencil as well as microfluidic patterning is that the cells confined by the patterns are still 
in a 2D environment and thus, fail to express the necessary interactions that are seen in 
vivo (Park and Shuler 2003). 
A 3D microenvironment is essential to recapitulate the in vivo tissue structures and 
architecture in vitro. 3D tumor models can vary from simple tumor spheroids to complex 
platforms consisting of detailed structure and multiple cell types (Nyga, Cheema, and 
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Loizidou 2011). The ECM provides important biochemical and biophysical cues which are 
essential for the development and progression of a tumor. Matrix stiffness, tissue structure 
and topography are some of the biophysical cues that are exhibited by the ECM and affect 
various functions and behaviors of the cell (Nikkhah, Edalat, et al. 2012). Tumor cells 
exhibit great plasticity under different conditions and 3D models have the ability to 
recapitulate these conditions to enable researchers to delineate and study the effect of 
individual microenvironmental cues on disease progression (Petersen et al. 1992, Bissell 
and Radisky 2001).  
Micro- and nanofabrication techniques have shown great promise in the recent 
years in creating 3D microenvironments with structures having precise geometry (Park and 
Shuler 2003). Specifically, these techniques have been instrumental to precisely control 
factors affecting the tumor at the micro- and nanoscale. Microfabrication techniques have 
been able to construct 3D platforms to study the effect of surface topographies on cancer 
cell behavior (Nikkhah, Edalat, et al. 2012). For instance, in studies conducted by Nikkhah 
et al., silicon surfaces were etched to form 3D microstructures in which human fibroblasts, 
normal breast epithelial cells as well as malignant breast cells were cultured (Strobl, 
Nikkhah, and Agah 2010, Nikkhah et al. 2011, Nikkhah et al. 2010, Nikkhah, Strobl, and 
Agah 2008, Nikkhah et al. 2009). It was observed that the fibroblast cells stretched across 
the curved walls of the microstructures whereas the malignant breast cells were seen to 
    
  19 
stretch or deform to take up the shape of 
 
Figure 1.3: Tumor models using microfabrication techniques (A) (i) HA/Fn patterned onto 
the surface of substrate using microcontact printing (ii) 24 hours into cell culture showing 
adhesion of MDA-MB-231 cells outside HA, HA (green) and Fn/CD44 (red), nuclei (blue). 
Scale bars = 100 µm. Adapted from Dickinson et. al. with permission from Royal Society 
of Chemistry [Lab on a Chip], copyright (2012) (Dickinson et al. 2012) (B)(i) Silicon 
microchannels formed by microfabrication techniques and visualized by scanning electron 
microscopy (SEM) (ii) Confocal images of actin and vinculin stained cells inside the 
microstructures. Scale bars = 20 µm. Adapted from Nikkhah et. al. with permission from 
Springer [Biomedical Microdevices], copyright (2010) (Nikkhah, Strobl, and Agah 2008) 
(C)(i)(a-e) Schematic showing the procedure to create PDMS microwells using PDMS and 
photolithography techniques, (ii) Representative images showing individual cells trapped 
in microwells of varying diameters (20-40 µm). Scale bar = 100 µm. Adapted from Rettig 
et. al. with permission from American Chemical Society [Analytical Chemistry], copyright 
(2005) (Rettig and Folch 2005)  
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the structure (Nikkhah, Strobl, and Agah 2008). In another study by the same group, co-
culturing normal breast epithelial cells and breast tumor cells showed that both the cell 
types spread according to the geometry of the cavity. However, when the cells were treated 
with an anti-cancer drug, the tumor cells were seen to display a stretched morphology, 
comparable to fibroblasts, but the normal mammary epithelial cells did not show a change 
in morphology (Figure 1.3 (B)) (Strobl, Nikkhah, and Agah 2010) . These topographies 
were formed in 3D but they lacked the essential ECM-like architecture that surrounds the 
cell and provides cues for proliferation, differentiation and migration.  
Microengineered 3D cell arrays are useful in drug screening as hundreds and 
thousands of samples can be tested on a single chip (Torisawa et al. 2007, Nikkhah et al. 
2013). For instance, in a study by Rettig et al. a large array of microwells was designed for  
trapping single cells (fibroblasts) and study the cellular behavior in general or their 
response to drugs, toxins (Rettig and Folch 2005). A master was first created using 
photolithography and then, the final chip was developed in PDMS using soft lithography 
(Figure 1.3 (C)) (Rettig and Folch 2005). In another study, a chip with an array of 
multiwells was used to study the proliferation, spheroid formation, and the response of 
breast cancer cell line (MCF 7) and hepatoma cell line (HepG2) to four different chemical 
stimuli (Torisawa et al. 2007). The microarray of multiwells was created by binding an 
anisotropically etched silicon substrate with pyramidal holes and PDMS microchannels 
made with the help of soft lithography techniques (Torisawa et al. 2007).  
Microfluidic technology can be used for designing single-cell, spheroid as well as 
co-culture assays (Wheeler et al. 2003, Kwapiszewska et al. 2014, Jeon et al. 2015). These 
systems have more control over the cell microenvironment as the factors surrounding the 
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cells can be manipulated through the channels that deliver media and soluble factors 
(Marimuthu and Kim 2011). Microfluidics can also be used for isolating circulating tumor 
cells (CTCs) (Moon et al. 2011, Kaiser 2010), studying tumor cell  
 
Figure 1.4: Representative microfluidic devices used in cancer studies. (A) (i and ii) Single 
channel microfluidic device with two parallel reservoir channels. (iii) Collagen gel with 
dye patterned (top row). Alternate channels patterned with collagen and Matrigel (bottom 
row). MDA MB 231 cells (green) cultured in collagen and the inset shows a cell crossing 
from collagen to Matrigel. Adapted from Huang et. al. with permission from Royal Society 
of Chemistry [Lab on a Chip], copyright (2009) (Huang et al. 2009)(B) (i)Transition of 
MCF-DCIS cells to IDC by compartmentalization in microfluidic device. (ii) The transition 
of MCF-DCIS cells into invasive phenotype is observed at the interface. Adapted from 
Sung et. al. with permission from Royal Society of Chemistry [Integrative Biology], 
copyright (2010) (Sung et al. 2011)(C) (i) Schematic representation showing two side 
channels and a gel channel in between which allowed the encapsulation of cells. (ii) (A) 
Cancer cells extravasating from the vascular network (B) Magnified images of the cancer 
cells extravasating. Adapted from Jeon et. al. with permission from National Academy of 
Sciences [PNAS], copyright (2015) (Jeon et al. 2015) 
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biology (e.g. invasion) (Song et al. 2009, Huang et al. 2009), and high throughput drug 
screening (Zhang and Nagrath 2013, Stern et al. 2010, Kim et al. 2012) and co-culture 
tumor and stromal cells to study their interaction. In a study by Huang et al., a microfluidic 
platform was designed having an array of microposts which allowed preferential filling of 
hydrogels into different channels. Using this device, metastatic breast cancer cells (MDA-
MB-231) and tumor derived macrophages were patterned into spatially defined geometries 
to study their interactions (Figure 1.4 (A) (i and ii)) (Huang et al. 2009). It was observed 
that over the 7 days of culture, the macrophages invaded into the adjacent gel and not into 
areas where no cells were present (Figure 1.4 (A) (iii)) (Huang et al. 2009). In another 
study, a compartmentalized microfluidic device was designed to study the transition of 
mammary epithelial cells (MCF-DCIS) from DCIS to IDC (Figure 1.4 (B) (i) (Sung et al. 
2011). Here, MCF-DCIS cells were patterned adjacent to human mammary fibroblasts 
(HMF) in order to recapitulate the in vivo microenvironment. Results showed that close 
contact between stromal fibroblast cells and MDF-DCIS aided in the transition to IDC 
(Figure 1.4 (B) (ii)) (Sung et al. 2011). In an alternate study, Jeon et al. created a 
microfluidic platform that could be used for studying the extravasation patterns of breast 
cancer cells, and also for drug screening applications (Figure 1.4 (C)) (Jeon et al. 2015). 
Microfluidic platforms have advantages such as flexibility in device design, low number 
of cells and less reagents needed. Microfluidic assays can be automated and real-time 
analysis can be performed on cell behavior (Halldorsson et al. 2015). Some challenges 
associated with microfluidics are the precise control of the environment surrounding the 
cells including parameters like chemical gradients, composition of the medium and shear 
stress experienced by the cells (Zhang and Nagrath 2013). Another limitation when 
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working with microfluidic devices is the inaccessibility and thus, the lack of ability of 
manipulation of the cells using force microscopy methods such as optical tweezers and 
atomic force microscopy.  
Self-assembling peptides and proteins can be also used to engineer 3D platforms 
which have precisely controlled formations at the nano-scale to develop scaffolds for 
culturing cancer cells (Zhang 2003). In the study by Yang et al. ovarian cancer cell lines 
were cultured in a 3D microenvironment formed by self-assembling RADA16-I peptide 
hydrogel (Yang and Zhao 2011). The three cell lines were seen to take up their respective 
distinct morphologies when cultured on RADA16-I scaffolds along with proliferative 
potential and high viability (Yang and Zhao 2011). Gelatin methacrylamide (GelMA) 
hydrogels have been also used for creating 3D cell cultures due to its biocompatibility and 
ability to be photocrosslinked. For instance in a recent study, GelMA was used for studying 
how the extracellular matrix contributes to the development and progression of the tumor 
in case of human glioblastoma multiforme (hGBM) (Pedron and Harley 2013). The 
concentration and the degree of methacrylation of the gel were varied to study its effect on 
the cultured tumor cells. The findings demonstrated proliferation and morphology of 
cancer cells in the different formulations of GelMA were observed and recorded (Pedron 
and Harley 2013). 
1.8 OBJECTIVE OF THE THESIS 
The objective of this thesis is to create a physiologically relevant breast tumor 
model which could be used to study cancer cell behavior (i.e. invasion) and ultimately, 
used for drug testing. The first step was to create a platform with high stiffness tumor 
regions and the surrounding stroma with lower stiffness. This was achieved by using 
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GelMA hydrogel and photolithography techniques. After the platform was validated, three 
different breast cell lines, highly invasive MDA-MB-231, non-invasive MCF-7 and normal 
mammary epithelial cells MCF-10A, were encapsulated in GelMA, patterned using a two-
step photolithography techniques and cell behavior was studied. Analyses performed 
included viability, proliferation, migration, quantification, and observation of 
morphological differences in the various regions of the 3D micropatterned platform.  
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CHAPTER 2  
A THREE DIMENSIONAL MICROPATTERNED TUMOR MODEL FOR BREAST 
CANCER CELL MIGRATION STUDIES 
2.1 INTRODUCTION 
 Metastatic dissemination of cancer cells is a highly complex and multi-step 
biological process starting with tumor angiogenesis (Braun and Naume 2005, Foroni et al. 
2012, Friedl and Wolf 2003) and the invasion of cancer cells through the ECM toward the 
blood vessels (Geiger and Peeper 2009, Lu, Weaver, and Werb 2012). Cancer cell invasion 
through the tumor stroma is governed by diverse factors including biochemical signals and 
biophysical cues (Foroni et al. 2012). Despite their significance, most in vivo animal 
models present an abundance of confounding variables making it challenging to attribute 
specific microenvironmental cues to cellular invasion (Van Dyke and Jacks 2002). In this 
regard, physiologically relevant in vitro tumor models are crucial to understand cancer cell 
invasion within a native-like breast tumor microenvironment.  
In the past few years, there has been a tremendous initiative to develop in vitro 
models to study cancer cell behavior in 3D microenvironments. For instance, 3D surface 
topographies have been widely used to study cancer cell behavior in response to various 
geometrical features (Lu, Weaver, and Werb 2012, Nikkhah, Edalat, et al. 2012, Nikkhah, 
Strobl, and Agah 2008, Nikkhah et al. 2010, Nikkhah et al. 2011). Despite their 
significance, these platforms lacked the capacity to alter the native-like parameters 
including stiffness and matrix architecture. Alternatively, a wide variety of 3D hydrogel-
based matrices such as Matrigel (Kleinman and Martin 2005), fibrin (Liu et al. 2012), 
collagen (Jeon et al. 2013, Szot et al. 2011), and PEG (Kharkar, Kiick, and Kloxin 2013) 
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have shown great promise to recapitulate cancer cell invasion in a 3D matrix and assess 
cellular behavior in response to various biophysical and biochemical cues. Such 3D 
hydrogel-based matrices enable cells to retain accurate phenotype and, consequently, 
exhibit precise responses to microenvironmental stimuli along with cell-cell and cell-
matrix interactions (Cukierman et al. 2001). Although these models have resulted in 
outstanding biological findings, they lack specific patterned features that would enable 
precise control over cellular distribution and matrix stiffness to conduct studies within 
biomimetic tumor architecture.  
The integration of microengineering technologies and advanced biomaterials (e.g. 
hydrogels) has offered great promises to develop well-defined microenvironments for 
fundamental biological studies.  These technologies are appealing since they enable tight 
control over the cellular microenvironment (Park and Shuler 2003). Particularly, through 
the use of phtotocrosslinkable hydrogels and micropatterning techniques, it is possible to 
generate biologically relevant constructs for tissue engineering and cancer related studies. 
However, there are still very few studies on the use of these types of hydrogels in the 
development of biologically relevant tumor models (Dickinson et al. 2012, Pedron and 
Harley 2013).  
In this study, we explore the use of a novel, two-step photolithography technique 
and GelMA hydrogel to develop a highly organized micropatterned breast tumor 
microenvironment model. GelMA has been proven to be an excellent candidate to generate 
biologically relevant constructs (Nichol et al. 2010) as cells have readily adhered to, 
proliferated within, and migrated when encapsulated within the 3D matrix of the hydrogel 
(Aubin et al. 2010, Nikkhah, Eshak, et al. 2012, Schuurman et al. 2013). More importantly, 
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the use of GelMA enables the creation of arrays of specific cell-laden features with high 
precision and fidelity (Van Den Bulcke et al. 2000). Previous studies using GelMA 
hydrogel have been largely focused on tissue engineering and regenerative medicine 
applications (Aubin et al. 2010, Nikkhah, Eshak, et al. 2012), with only a few focused on 
cancer (Kaemmerer et al. 2014, Pedron and Harley 2013). The proposed platform, 
presented herein, has unique advantages through the ability to independently decouple 
different cell-embedded regions within the tumor model and independently tune their 
stiffness. Furthermore, the microfabricated model enables precise visualization of cancer 
cell migration within a 3D matrix in response to microenvironmental cues. In order to 
validate the proposed microengineered tumor model, we primarily assessed the 
morphology and proliferation of highly invasive human breast cancer MDA-MB-231 cells, 
non-invasive, tumorigenic human breast cancer MCF7 cells, and normal mammary 
epithelial MCF10A cells. In addition, we analyzed migration and cytoskeletal organization 
of the cells within different regions within the micropatterned breast tumor constructs.  
2.2 MATERIALS AND METHODS 
2.2.1. Synthesis of GelMA Hydrogels 
 GelMA preparation was completed similar to prior studies (Nichol et al. 2010, Van 
Den Bulcke et al. 2000). Primarily, a 10% w/v solution of type A porcine skin gelatin was 
prepared in Dulbecco's phosphate buffered saline (DPBS; Gibco). This solution was made 
at 60 °C in order to fully dissolve before proceeding to subsequent steps. Methacrylic 
anhydride was then added drop-wise to infuse it within the gelatin solution. The mixture 
was then stirred vigorously for three hours as to ensure the completion of the reaction. In 
order to shift the equilibrium and stop the reaction, the reaction mixture was diluted (5X) 
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with warm (40 °C) DPBS. This crude prepolymer GelMA was dialyzed for one week in 
distilled water (replaced twice a day) using dialysis membranes (MWCO 12000-14000) at 
a constant temperature (40 °C) to filter out any salt byproducts created from the reaction 
between gelatin and methacrylic anhydride. The desired degree of methacrylation was 
achieved by precisely controlling the proportion of methacrylic anhydride to gelatin during 
synthesis (92±2% confirmed based on 1H NMR). The gelatin methacrylate solution was 
lyophilized for one week to create a dehydrated, porous macromer, which could be 
preserved for future experiments. 
2.2.2. Cell Culture 
 The invasive breast cancer MDA-MB-231 cell line, tumorigenic breast cancer 
MCF7 cell line, and mammary epithelial MCF10A cell line were used in this study. Cancer 
cells were maintained in 1X Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, and 1% 50:50 
penicillin:streptomycin. Mammary epithelial cells were maintained in DMEM:F12 
supplemented with 1% L-glutamine, epidermal growth factor (20ng/mL), cholera toxin 
(100ng/mL), insulin (10μg/mL), hydrocortisone (0.5mg/mL), and 5% horse serum. All 
media and media supplements were provided by Life Technologies. Cells were kept at a 
standard physiological condition (humidified, 37 °C, 5% CO2), were passaged weekly, and 
had their media changed every three days in order to produce a controlled experimental 
condition.      
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2.2.3. Microfabrication of the Tumor Model 
 In order to promote adherence of the GelMA hydrogel constructs, glass slides were 
functionalized with 3-(trimethoxysilyl)propyl methacrylate (TMSPMA) (Sigma) as 
described in previous protocols (Aubin et al. 2010, Nikkhah, Eshak, et al. 2012). 
Subsequently, a 7 µL drop of 20% (w/v) PEG prepolymer solution included with 0.5% 
(w/v) photoinitiator (PI) (2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-propanone) 
was placed onto cut (area: <1cm2), sterilized glass slides. An untreated coverslip was 
placed on top of the PEG prepolymer and this arrangement was then exposed to ultraviolet 
(UV) light (360-480nm, 800 mW) for 50s which crosslinked to form a thin layer of PEG 
coating on the TMSPMA-treated glass slides.  
 To microengineer the tumor model, GelMA macromer was dissolved in DPBS 
containing 0.5% (w/v) PI. This formed a prepolymer solution, which was stored at 37 °C. 
Cells were encapsulated in the prepolymer solution through resuspension of pelleted cells 
(cell density: 6 x 106 cells per mL of GelMA). The tumor model was patterned by first 
pipetting a 15 µL droplet of cancer cell-laden GelMA onto a spacer (depth: 100 µm). A 
PEG-coated glass slide was then inverted on top of the spacer thereby spreading the 
prepolymer solution to cover the area of the glass slide and fill in the 100 µm depth of the 
spacer (Figure 2.1A-B). A photomask (designed with AutoCAD software and printed by 
CAD/Art Services Inc., Orgeon) was then placed on the inverted, PEG-coated glass slide 
and exposed to UV light for 12s (Figure 2.1C). Tumor models were created with three 
different geometrical parameters. Photomasks with an 11x11 array of translucent circles of 
diameters 100, 250 and 500 µm and surrounded by a black unpatterned area were used to 
create the high density array of tumors. The spacing between the circles was a constant 750 
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µm and the height of the tumor regions were 100 µm. Upon UV exposure, the patterned 
glass slide was washed to remove the excess cells and stored in a petri dish filled with 
DPBS. Following, a 13 µL drop of pristine GelMA (no cells) was placed onto the spacer 
and the patterned glass slide was inverted on top of it (Figure 2.1D-E). The circular 
constructs guided the spread of the pristine GelMA to the surrounding areas. This assembly 
was exposed to UV light for another 5s in order to crosslink the gel filled in between the 
circular constructs (Figure 2.1F). Upon completion of the experiment, the micropatterned 
tumor model were transferred from the DPBS baths to 24-well cell culture plates with 
media corresponding to each cell line. Cell culture media was changed every three days 
over the course of the experiments. 
2.2.4. Stiffness Measurements with Atomic Force Microscopy (AFM) 
 GelMA stiffness measurements were performed with a MFP-3D AFM (Asylum 
Research) placed on an inverted microscope (IX71, Olympus) (Fuhrmann et al. 2011, 
Physical Sciences - Oncology Centers et al. 2013, Schulz et al. 2010). A 40X objective 
with a NA of 0.65 (Olympus) was used to perform force measurements on the center of the 
circular GelMA microstructures. Large radius tip AFM probes (LRCH-750, Team 
NanoTec) with a tip radius of ~810nm were used (Figure 2.1C). The thermal energy 
dissipation method (Butt and Jaschke 1995) was used to determine the spring constant of 
the cantilevers (~0.15 N/m). Four force-indentation measurements were taken in a 90µm2 
area at the center of 8 different circular GelMA microstructures. Alternatively, forty force-
indentation measurements in a 90µm2 area were taken on the non-patterned GelMA 
surface. Approach and retraction speed for all measurements was 2µm/s. A trigger force of 
10nN was used for all force-indentation measurements. All measurements were done in 
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10X DPBS buffer solution. Young’s Moduli from force indentation curves were 
determined using custom MATLAB routines. Force-indentation curves were analyzed 
using the power-law linearization method as described previously (Guo and Akhremitchev 
2006) based on the Briscoe indentation model for a blunted cone with a Poisson ratio of 
0.5. 
 2.2.5. Cell Viability Assay 
 Cell viability was assessed on day 5 using a standard Live/Dead Assay Kit 
(Invitrogen), which includes calcein AM (CI) and ethidium homodimer (ETD). To prepare 
the solution, 0.5 µl CI and 2 µl ETD were added to 1 mL DPBS. After 5 days of culture, 
the microenvironments were rinsed with warm DPBS and 150 µl of the CI/ETD solution 
was added to each well. The well plate was stored at physiological conditions (37 °C, 
humidified, 5% CO2) and imaged after 30 minutes using an inverted fluorescence 
microscope (Zeiss Axio Observer Z1) with 10X magnification.  
2.2.6. Quantification of Cell Proliferation 
 Cell proliferation was quantified through counting cell nuclei on days 0, 1, 3 and 5 
of culture. The cell-laden GelMA hydrogel constructs were rinsed with DPBS and fixed 
with 4% paraformaldehyde (PFA) solution in DPBS. After 30 minutes, the samples were 
washed three times (3X) in DPBS. A 0.1% (v/v) of DAPI (4’,6-diamidino-2-phenylindole) 
(Life Technologies) in DPBS solution was prepared and added to each well. The samples 
were left in DAPI contained solution for 15 minutes, and then washed 3X in DPBS. The 
samples were fluorescently imaged, and the number of DAPI stained nuclei were counted 
using ImageJ (v. 1.48) software to determine proliferation and migration of each cell line 
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at specific time points (Days 0, 1, 3 and 5). At least three samples were prepared for each 
condition within each experiment.  
2.2.7. Actin Cytoskeletal Organization  
 To assess F-actin cytoskeletal organization, cell encapsulated hydrogel constructs 
were fixed with 4% PFA solution in DPBS and then permeabilized for with 0.1% Triton 
X-100. The samples were washed 3X in DPBS with 5-minute intervals. The cell 
encapsulated hydrogel constructs were then blocked with 1% bovine serum albumin (BSA) 
for 1 hour. A 1/40 dilution of Alexa Fluor-488 phalloidin (Life Technologies) in 0.1% BSA 
was added to the blocked samples for 45 minutes. The hydrogel constructs were 
subsequently washed 3X in DPBS. Upon F-actin staining, the cells were stained with DAPI 
to visualize the nuclei. The stained samples were inverted onto a glass coverslip with a 
droplet of ProLong Diamond Antifade solution. The cell-encapsulated hydrogel constructs 
were imaged using a fluorescence microscope (Zeiss Axio Observer Z1) equipped with an 
Apotome.2 at 20X/40X magnification. Z-stacks and 2X2 tiles of the samples were obtained 
and 3D images were constructed using the Zen software. Circularity of the cells was 
determined by using top-view images of fluorescent F-actin staining. These images of 
individual constructs were fed into a custom script for the ImageJ software, which 
compared each individual clump or each individual cell to a perfect reference circle, 
outputting a percent circularity value.  
2.2.8. Data Collection and Statistical Analysis 
 Migration and proliferation data were analyzed over the course of three experiments 
(n=3) for each cell line. Each experiment (sample) had three replicates for a total of nine 
replicates per cell line at each time point (Days 0, 1, 3, 5). The data was collected within a 
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5X5 array of constructs in the center of each replicate. Data for the live-dead analysis had 
the same method of data collection in terms of experiments, sample sizes, and replicates 
on day 5 of culture. Data for circularity was collected by measuring the circularity of the 
cells within the triplicate samples of one experiment for each of the three cell types. 
A one-way analysis of variance (ANOVA) was conducted, which demonstrated 
statistically significant differences between each group when α = 0.05. A Bonferroni's post-
hoc test was subsequently completed in order to measure statistically significant 
differences between individual groups. All data were presented in mean ± standard 
deviation (SD). Statistical analysis/data presentation were performed in Graph Pad Prism 
(v. 6.0). 
2.3 RESULTS 
2.3.1. Microfabrication and Characterization of the Tumor Model  
 The microengineered tumor model was developed using 5% GelMA with high 
(92±2%) degree of methacrylation due to its biocompatibility and reliability for 
photolithography applications (Nichol et al. 2010, Nikkhah, Eshak, et al. 2012, Nikkhah et 
al. 2010). The specific geometrical parameters of the microengineered tumor model are 
defined in Table 1. 
Table 1: Geometrical features of the microengineered tumor model* 
Shape 
Depth 
(µm) 
Diameter 
(µm) 
Spacing 
(µm)** 
Surface ratio 
construct/surrounding 
Circle 100 500 750 0.536 
*Visualized in Figure 2.2 A 
**Spacing refers to the distance between the radii of adjacent tumor construct  
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The thickness of the tumor constructs was set to 100 µm due to its proven efficacy 
in the formation of patterned cellular constructs (Nikkhah, Eshak, et al. 2012). The 
 
Figure 2.1: Schematic diagram depicting the development of array of the proposed tumor 
model. (A) A drop of breast cancer cells encapsulated in GelMA prepolymer solution was 
pipetted onto a spacer and a glass slide/photomask was layered on top of it. (B,C) UV light 
is exposed to crosslink GelMA to create an array of high stiffness circular constructs. (D) 
A drop of pristine GelMA prepolymer solution was pipetted onto a spacer and the 
micropatterned circular constructs from (C) was placed on top of it, thereby spreading the 
hydrogel in between the constructs. (E) UV light was exposed to crosslink the surrounding 
matrix. (F) Representative schematic of the final microengineered tumor model with the 
high stiffness tumor constructs surrounded by low stiffness matrix. 
spacing and diameter of the cell encapsulated circular constructs were optimized based on 
a series of preliminary experiments (data not presented). After the preliminary studies with 
three different dimensions, it was observed that the tumorous circular regions with a 
diameter of 500 µm gave the best results for visualizing the dissemination and migration 
of the cancerous malignant MDA-MB-231 cells. The cellular constructs with 100 and 250 
µm had low fidelity. Therefore, all the ensuing experiments were performed using the 
geometrical features defined in Table 1. Upon optimization, separate aliquots of GelMA 
prepolymer solution were stained with 0.01% rhodamine and 0.01% fluorescein dye to 
visualize the localization of hydrogel constructs after micropatterning. The developed two-
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step photolithography technique, as demonstrated in Figure 2.1, was used to form high 
density array of circular constructs (red stained hydrogel) surrounded by a surrounding 
matrix (green stained hydrogel). In particular, the two-step process involved  
 
Figure 2.2: Representative fluorescence image (A) of Rhodamine B stained circular 
constructs and Fluorescein stained surrounding matrix. (B) Schematic diagram of the AFM 
setup to perform local stiffness measurements. (C) SEM image of the AFM cantilever used 
to probe the hydrogel (radius of tip: 810nm; scale bar represents 1 μm). (D) Mechanical 
stiffness of the circular constructs and the surrounding matrix reveal a Young's modulus of 
748 ± 90 and 313± 38 Pa respectively. Data is presented in mean ± SD. (*p<0.05) 
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fabricating the circular constructs first (Figure 2.1 A-C), and, subsequently, filling in the 
surrounding regions by adding GelMA prepolymer in between the constructs (Figure 2.2 
D-F). The circular constructs were, as such, crosslinked more than the surrounding matrix. 
As the crosslinking time of the prepolymer solution has a direct positive correlation to the 
stiffness of the GelMA hydrogel (Nichol et al. 2010), we expected that this method would 
create cell-embedded circular constructs with  stiffness that is substantially higher than the 
surrounding matrix to assess the capability of the proposed microfabrication technique in 
forming areas of differential stiffness on a single chip, the Young's moduli of the circular 
constructs and the surrounding regions (interstitial area) were measured by AFM (Figure 
2.2 B, C). These measurements revealed a stiffness of 747.8 ± 89.6 Pa within the circular 
constructs which was over twice as stiff as the interstitial area measured at 313.3 ± 37.5 Pa 
(Figure 2.2 D). These data indicated the fidelity and reliability of the proposed two-step 
photolithography technique to create a high-density array of constructs with adjustable 
stiffness. 
2.3.2. Cell Viability 
 We evaluated viability of three distinct cell types, normal mammary epithelial 
MCF10A cells, tumorigenic MCF7 cells, and highly invasive breast cancer MDA-MB-231 
cells encapsulated within the microengineered tumor model. Representative images of the 
cell viability experiments (Figure 2.3A) demonstrated excellent cell survival upon 
encapsulation and the microfabrication procedure. The percent of viable cells across all the 
three cell types had no statistically significant difference and was within 84 ± 5% after 5 
days of culture (Figure 2.3B). Similarly, in previous studies, a wide array of other cell 
types such as ovarian cancer cells, 3T3 fibroblast cells, and human umbilical vein 
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endothelial cells (HUVECs), encapsulated within GelMA hydrogel, exhibited high percent 
cell survival upon micropatterning(Kaemmerer et al. 2014, Nichol et al. 2010, Nikkhah, 
Eshak, et al. 2012). Thus, our data confirmed that the specific parameters used to 
microengineer the tumor model (the two-step, 17 second UV exposure and presence of PI 
within the prepolymer solution) did not have a substantial effect on overall cell viability.  
 
Figure 2.3: Representative fluorescence images (A) of cell-embedded tumor model stained 
with a live/dead assay on day 5 of culture (Live cells: green; Dead cells: red). No 
statistically significant difference observed between three cell types (B). Data is presented 
in mean ± SD. Scale bars represent 200 μm. 
2.3.3. Cell Morphology, Migration, and Proliferation within the micropatterned 
constructs 
 Phase contrast images demonstrated that the three cell types (MCF10A, MCF7, 
MDA-MB-213) were homogeneously distributed throughout the hydrogel and had a round 
morphology on day 0 immediately after encapsulation within the micropatterned circular 
regions. However, between days 1 and 3 of culture, the cells began to exhibit characteristics 
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specific to the cell type. In particular, MDA-MB-231 cells adopted a heterogeneous 
morphology, both round and elongated, with higher cell density secondary to their high 
proliferative capacity (Nagaraja et al. 2005) (Figure 2.4 A). These cells started migrating 
toward the outer regions of the circular constructs as early as day 3 of culture, which was 
further evident on day 5 of culture (Arrows, Figure 2.4 A; Figure 2.5). MCF7 cells formed 
clusters within and on the periphery of the constructs and  
 
Figure 2.4: Representative phase contrast images demonstrating changes in cellular 
morphology. MDA-MB-231 cells spread rapidly creating a heterogeneous (spindle vs. 
round) morphology. Arrows point to cells that have invaded the surrounding stroma. MCF7 
cells exhibited a tendency to cluster, demonstrating only weak migration on days 1 and 3 
of culture and small clusters by day 5. MCF10A cells formed similar clusters by day 3 
which grew bigger by day 5. Scale bars represent 100μm. 
exhibited weak migratory characteristics and elongation toward the surrounding regions as 
early as day 1 of culture (Arrows, Figure 2.4 B). These cells had no indication of an 
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invasive phenotype by day 5 as they lost their elongated morphologies and quickly 
began to form clusters (Figure 2.4 B). Similarly, MCF10A cells also formed cellular 
clusters upon day 1 of culture and demonstrated no significant migratory 
characteristics (Figure 2.4 C). These cells maintained round morphology, while the 
size of the cellular clusters notably increased as a function of time. 
 
Figure 2.5: Phase contrast (3X3 tile) images of a high density array of tumor constructs 
demonstrating cellular morphology and migration. Scale bars represent 250 μm. 
To prevent cellular attachment on glass slide and guide the migration throughout 
the 3D hydrogel constructs, a layer of PEG was coated onto the glass slide due to its cell-
repellant properties (Nikkhah, Eshak, et al. 2012). Control experiments were conducted 
where the circular constructs were patterned onto glass slides with and without PEG 
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coating. When patterned on slides without PEG, nearly every single cell escaped from the 
miropatterned circular regions and migrated onto the glass slide (Figure 2.6). These results 
indicate that, without PEG, the cells heavily adhered to and interfaced with the 
 
Figure 2.6: Phase contrast images of a control experiment using MDA-MB-231 cells. In 
the presence of PEG, cells were confined within the circular constructs at all time points. 
Without PEG coating, cells migrated down to the glass slide before diffusely migrating on 
the glass slide. Scale bars represent 200 μm. 
glass slide. On the other hand, adding PEG coating resulted in cell-repelling properties 
and facilitated the migration of the cells throughout the hydrogel layer.   
Consistent with phase contrast images, fluorescence images of DAPI stained 
cell nuclei demonstrated a significantly higher number of MDA-MB-231 cells within 
the circular constructs and the surrounding matrix as compared to MCF7 and 
MCF10A cells.  Cellular clustering was also evident in DAPI stained MCF7 and MCF10A 
cells (Figure 2.7 A).  Quantitative analyses confirmed that the overall MDA-MB-231 
proliferation was significantly higher compared to MCF7 and MCF10A cells within the 
microengineered platform (Figure 2.7 B). Particularly, a similar trend was observed 
with respect to the number of the cells within the high stiffness circular constructs 
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(Figure 2.7 C). About 2.5 times more MDA-MB-231 cells disseminated from the 
circular areas toward the surrounding matrix by day 5 of culture as compared to 
MCF7 cells (12.87 ± 1.85% vs 5.16 ± 2.31%). MCF10A cells exhibited nearly no 
invasive characteristics toward the outer regions of circular constructs (1.08 ± 0.24% 
by day 5) (Figure 2.7 D). However, there was still a statistically significant difference 
in the migration of MCF10A cells at each time point. This is due to the clumping 
tendency as some cells proliferated to form clusters on the edge of the constructs. 
Differences in migratory characteristics of the cells were further highlighted in the 
real time experimentations (Supplementary Movies M-1, M-2, M-3). MDA-MB-231 
cells were shown to elongate at the periphery of the constructs prior to contractile 
motion, which guided them out of the constructs.  It is also important to note that 
these cells demonstrated the ability to migrate between and back into constructs after 
initially invading the surrounding matrix (Supplementary Movie M-4). Consequently, 
migration data presented consists of net migration values counting only the cells that 
have entered and remain in the surrounding matrix by day 5 of culture.  
2.3.4. Actin Cytoskeletal Organization 
 To further confirm our observations on cellular migration and gain insight into 
cell-matrix interactions/morphology, we performed 3D imaging of the actin 
cytoskeletal organization of cells embedded throughout the hydrogel layer (100 μm 
height). Preliminary images clearly demonstrated the cells were embedded within 
the hydrogel layer of the high stiffness circular constructs (Figure 2.8A) as well as the 
surrounding matrix (Figure 2.8B). 
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Figure 2.7: Migration and proliferation of the cells within the tumor model. Representative 
fluorescence images (A) demonstrating DAPI stained cell nuclei. Total cell proliferation 
(B), cell proliferation within the tumor region (C), and cellular invasion (D). Scale bars 
represent 200 μm. *p<0.05 compared to the previous time point. 
Using Z-stack microscopy imaging of the actin cytoskeleton, we were able to 
visualize the 3D structure of the cells.  We observed several different structures including 
3D elongated protrusions, flat protrusions and membrane blebs (Figure 2.9, arrows). In the 
representative images of the F-actin cytoskeleton, MDA-MB-231 cells particularly 
exhibited a wide range of invasive characteristics possessing small number of flat 
protrusions and many elongated 3D protrusions. In addition some cells exhibited 
membrane blebs as they invaded the surrounding matrix (Figure 2.9A, D). A few number 
of MCF7 cells exhibited flat protrusions, on the periphery of the circular constructs, as 
demonstrated in the representative high magnification (40x) images (Figure 2.9 E). In 
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MCF10A cells, the clustering tendency was significantly higher with no indications of 
protrusions. To further quantify cellular morphology, the circularity of the actin 
cytoskeleton was assessed within the three cell types (Figure 2.9 G) using a custom script 
for Image J software (particle analyzer module). This analysis revealed that MDA-MB-231 
cells exhibited a significantly less circular morphology when compared to MCF7 and 
MCF10A cells, as demonstrated by the high standard deviation indicative of their 
heterogeneous morphology (Figure 2.9 G). 
 
 
Figure 2.8: F-actin cytoskeletal organization of the cells demonstrating cells embedded 
within the hydrogel layer. Some MDA-MB-231 cells migrated to the glass slide and 
demonstrate a flat protrusions. These cells also exhibited 3D actin protrusions and 
membrane blebs. 
2.4 DISCUSSION 
 The development of 3D in vitro breast tumor models is significant for cancer related 
studies, since it would enable us to perform fundamental biological analyses on metastatic 
processes, such as cancer cell invasion. Furthermore, biomimetic tumor models can 
facilitate high throughput analyses on the efficacy of various pharmaceuticals compounds 
on cancer cell invasion. Currently, a wide variety of 2D and 3D platforms are being used 
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to study breast cancer cell behavior (i.e. migration, gene expression). 2D assays do not 
recapitulate the complexities of the native tumor microenvironment (Griffith and Swartz 
2006, Kim 2005). On the other hand, the majority of 3D hydrogel-based matrices lack 
organized architecture and cellular constructs, thus are limited in terms of localizing the 
stromal components and cancer cells within separate regions (Kimlin, Casagrande, and 
Virador 2013).   
 
Figure 2.9: F-actin (green) and DAPI (blue) stained cell-embedded tumor model on day 5 
of culture. (A-C) Representative 20X image of MDA-MB-231, MCF7, and MCF10A cells 
respectively. (D-F) Representative 40X images highlighting specific cell-matrix 
interactions. (G) Circularity amongst the three cell types. MCF10A, MCF7, and MDA-
MB-231 cells had circularities of 74.9 ± 12.1%, 72.1 ± 15.7%, and 57.3 ± 24.7% 
respectively (*p<0.05). 
It is now becoming more recognized that the integration of microfabrication 
techniques and advanced biomaterials (i.e. photocrosslinkable hydrogels) can provide a 
unique ability to develop highly organized cell-based constructs (Dickinson et al. 2012, 
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Dolatshahi-Pirouz et al. 2014, Kimlin, Casagrande, and Virador 2013). In this regard, 
GelMA hydrogel is an excellent candidate for cancer related studies due to its 
biocompatibility and ability to create organized cellular constructs. However, the primary 
focus on the use of GelMA, thus far, has been centered on tissue engineering and 
regenerative medicine applications (e.g. formation of vascularized networks (Nikkhah, 
Eshak, et al. 2012)). To our knowledge, there has not been any specific study utilizing 
GelMA to develop microengineered breast tumor models. Furthermore, there have been no 
significant attempts, using hydrogel-based matrices, to localize the separate regions with 
tunable stiffness (i.e. circular constructs, surrounding region) within microengineered 
platforms. In this work, we build upon our expertise in microfabrication technology by 
creating a novel, two-step photolithography technique to develop a 3D highly organized 
breast tumor microenvironment. GelMA has been demonstrated to be a biocompatible 
matrix for encapsulation with a vast array of cell types including 3T3 fibroblasts, 
endothelial cells, aortic valvular interstitial cells, and glioma cells (Aubin et al. 2010, 
Benton et al. 2009, Nikkhah, Eshak, et al. 2012, Pedron and Harley 2013). Consistent with 
previous studies, our work also confirmed that breast cancer and mammary epithelial cells 
had around 85% viability, indicating that the two-step photolithography technique along 
with the UV exposure and the presence of a PI had minimal effect on overall cell survival. 
Furthermore, the crosslinking time of the GelMA (12s) resulted in a Young's modulus of 
about 750 Pa. This is consistent with previous studies where a crosslinking time of 60s 
yielded a Young's modulus of 3.5-4 kPa (Nichol et al. 2010) indicating that the stiffness of 
the GelMA might be linearly dependent on the crosslinking time.  
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An innovative aspect of our study was independently patterning 3D high stiffness 
circular constructs surrounded by an interstitial area of lower stiffness (surrounding 
regions). Matrix stiffness demonstrates a physiologically relevant condition and has 
consequently been heavily studied in collagen, polyacrylamide, and Matrigel hydrogels 
(Kraning-Rush and Reinhart-King 2012, Zaman et al. 2006). Furthermore, several studies 
have focused on seeding the cells on hydrogel sheets (Kraning-Rush and Reinhart-King 
2012) with different stiffness rather than encapsulating them within the 3D matrix. In this 
regard, our model provides a distinct advantage, as we are able to independently modulate 
the stiffness of the matrix within distinguished regions in the microengineered tumor 
model. As such, we can assess the specific effects of matrix stiffness on breast carcinoma 
progression in vitro within a 3D model. In our model, it was demonstrated that some MDA-
MB-231 cells were highly populated in the higher stiffness circular constructs. Although 
significant number of cells initially invaded within the surrounding regions of lower 
stiffness, but real time analysis demonstrated that some cells gained an affinity to move 
back into the high stiffness circular areas (Supplementary Movie M-4). Such behavior 
indicates the tendency of cancer cells to migrate within the stiffer regions. Using our 
proposed microengineering technique, our future studies will be focused on switching the 
stiffness of the circular constructs and the surrounding matrix.   
 The proposed micropatterned tumor model also shed unique insight on cancer cell 
morphology. MDA-MB-231 cells adopted highly invasive characteristics with a mixture 
of round and spindle like morphologies. Specifically, the cells that migrated down on the 
glass slide formed flat protrusions, which was substantially different than the morphology 
exhibited by the cells embedded within the 3D gel (Arrows, Figure 2.8B). This bi-modal 
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display of migratory morphology demonstrates that the mechanism for MDA-MB-231 
cells migration was heavily influenced by substrate interactions (2D vs 3D).  Particularly, 
cells migrating through the hydrogel formed 3D protrusions or membrane blebs (Arrows, 
Figure 2.8A; Supplementary Movie M-5). These observations were consistent with the 
heterogeneous, 3D morphology of migrating cells cultured in Cell Derived Matrix (CDM) 
and Matrigel (Petrie and Yamada 2012, Poincloux et al. 2011). In order to fully guide the 
migration of the cells through the 3D hydrogel gel, further modifications (i.e. concentration 
of PEG,) are required to further enhance cellular repellency of PEG layer. MCF7 and 
MCF10A cells rapidly clustered as early as day 2/3 that only grew bigger by day 5. In fact, 
there are numerous studies that have utilized various biochemical signals (i.e Cyclic AMP) 
or the co-cultures with CAFs in order to produce stimulate growth of morphologically 
accurate cellular clusters similar to acinar structures (Krause et al. 2010, Nedvetsky et al. 
2012). Within GelMA hydrogel, these cells formed clustered without the need for any 
biochemical stimuli, which further validates our model by confirming that it can readily 
recreate in vivo like morphologies.  
The proposed photocrosslinkable hydrogel along with the two-step 
photolithography technique can be used to create tumor microenvironment models that 
have significant applicability in terms of modeling a physiologically relevant diseased 
condition. Specifically, matrix stiffness can be modified, cellular composition and 
organization can be tweaked, and biochemical stimuli can be added to the environment in 
an organized manner. The microenvironment remains to be a high-density, quantifiable, 
and morphologically accurate model regardless of the study. This has significant 
applicability in terms of high-throughput drug testing, the development of personalized 
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medicine, as well as in fundamental studies of cancer biology. In the future, we plan to 
build upon this microenvironment by conducting detailed studies on effects of matrix 
stiffness on migration/morphology and the introduction of stromal components within the 
tumor model.   
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CHAPTER 3  
CONCLUSION AND FUTURE WORK 
3.1 CONCLUSION  
Breast cancer is one of the most commonly diagnosed cancers and results in a high 
mortality rate in U.S. women. Therefore, it is crucial to study the behavior of cancer cells 
and ultimately, their response to anti-cancer drugs. In this study, we created a tumor model 
using a novel, two-step photolithography technique and photocrosslinkable gelatin 
hydrogel. A unique aspect of our model was the compartmentalization of two distinct 
regions juxtaposed to each other with differential stiffness. In particular, we developed high 
density array of cell embedded high stiffness circular regions surrounded by low stiffness 
areas. We validated the model by encapsulating three cell types separately in order to 
investigate migratory behavior, cell viability, and cell morphology. High cell survival 
(~85%) as compared to previous studies was observed regardless of the cell type. 
Interestingly, a bimodal display of morphology was displayed in MDA-MB-231 cells as 
they elongated with flat protrusions on glass slid while exhibited 3D protrusions or 
membrane blebs when invading the surrounding hydrogel matrix. These cells were highly 
populated at the high stiffness circular constructs. In addition, 3D cellular clusters were 
observed in both MCF7 and MCF10A cells. These morphologically accurate structures 
were formed without the use of any biochemical stimuli, which demonstrates the versatility 
of GelMA in creating a biomimetic tumor microenvironment. The proposed platform could 
be potentially used for future studies of cancer cell behavior, high-throughput drug 
screening, and the development of personalized medicine. Some of the other advantages of 
our approach relative to microfluidics is the ease of fabrication, high density arrays which 
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can be used for high throughput studies, and the increased accessibility which can be used 
for various probing techniques such as AFM, optical tweezers, etc.  
3.2 FUTURE WORK 
3.2.1 Co-culture of cells in the 3D microenvironment 
 In our study, we used one cell-line encapsulated within the GelMA hydrogel and 
patterned into circular tumorous regions. Owing to the complexity of the breast tumor 
architecture, and in order to recapitulate the in vivo microenvironment, other cell types of 
the breast stroma can be introduced into this model. For example, CAFs can be introduced 
into the stromal region surrounding the tumors. The effect of CAFs on the proliferation and 
migration of the three breast cell lines can be observed and analyzed. Addition of 
endothelial cells to study the capillary formation and effect of those capillaries on the 
migration of the breast cell lines is another facet which can be looked into. Another 
interesting study could be mixing the different stromal components in the ratio observed in 
vivo and analyzing their effect on the migration and morphological changes in breast cancer 
cell lines. 
3.2.2 Effect of varying stiffness of the tumor constructs with respect to the surrounding 
stroma 
 Mechanical force exerted by the surrounding environment is a crucial component 
in determining the fate of cancer cells, their transition into a tumorous phenotype, invasion 
and migration through the neighboring tissue. We studied the effect of high stiffness 
tumorous regions surrounded by a lower stiffness stroma on the migration and morphology 
of three different breast cell lines. An interesting study would be to look at the effect of 
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varying stiffness on the migration trajectory of the breast cancer cell lines in 3D. This 
would give insight to the cancer cell migratory patterns in case of changing stiffness.  
3.2.3 Addition of anti-cancer drugs to the 3D tumor microenvironment 
 Cancer cell behavior in the developed platform is seen to mimic that in the in vivo 
microenvironment. An interesting study would be the addition of an anti-cancer drug to the 
cell encapsulated in high density array of tumors. Drugs can be added to assess the changes 
in proliferation and migration of the cancer cells. Morphological changes and cytoskeletal 
reorganization in the tumor cells can also be analyzed in response to the anti-cancer drug. 
Thus, this platform could be a potent candidate after appropriate calibration and validation 
to be used for drug screening and ultimately, in personalized medicine.  
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